Literature DB >> 5799123

Inhibition of the hepatic metabolism of amphetamine by desipramine.

J V Dingell, A D Bass.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5799123     DOI: 10.1016/0006-2952(69)90271-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Uptake, subcellular distribution, and transfer processes of imipramine and its metabolites formed in rat liver perfusion systems.

Authors:  M H Bickel; H Börner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

2.  Metabolism of a pharmacologically active pyrrolidine derivative (prolintane) by lactam formation.

Authors:  H B Hucker; S C Stauffer; R E Rhodes
Journal:  Experientia       Date:  1972-04-15

3.  Species differences in the metabolism of norephedrine in man, rabbit and rat.

Authors:  J E Sinsheimer; L G Dring; R T Williams
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

4.  Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man.

Authors:  L F Gram; K F Overo
Journal:  Br Med J       Date:  1972-02-19

5.  Acute treatment with desipramine stimulates melatonin and 6-sulphatoxy melatonin production in man.

Authors:  C Franey; M Aldhous; S Burton; S Checkley; J Arendt
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

6.  Biliary excretion of amphetamine and methamphetamine in the rat.

Authors:  J Caldwell; L G Dring; R T Williams
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.